Dynamics of Sendai virus spread, clearance, and immunotherapeutic efficacy after hematopoietic cell transplant imaged noninvasively in mice

Medicine & Life Sciences

• Sendai virus 92%
• Respirovirus 55%
• Rubulavirus 54%
• Adoptive Transfer 47%
• Viruses 46%
• Transplants 43%
• Respiratory Tract Infections 38%
• Respirovirus Infections 33%
• Infections 26%
• T-Lymphocytes 25%
• Virus Diseases 20%
• Monoclonal Antibodies 20%
• Respiratory Tract Diseases 19%
• Paramyxoviridae Infections 18%
• Respiratory Syncytial Viruses 16%
• Time-to-Treatment 15%
• Granulocyte Colony-Stimulating Factor 14%
• Immunocompromised Host 14%
• Orthomyxoviridae 13%
• Luciferases 12%
• Natural Killer Cells 12%
• Immunotherapy 12%
• Therapeutics 11%
• Vaccines 10%
• Animal Models 9%
• Morbidity 8%
• Lung 7%
• Mortality 6%

Agriculture & Biology

• Murine respirovirus 100%
• viruses 44%
• mice 39%
• infection 31%
• Orthorubulavirus 31%
• disease severity 30%
• T-lymphocytes 27%
• Human respirovirus 1 22%
• cells 21%
• respiratory tract diseases 21%
• Human respirovirus 3 20%
• monoclonal antibodies 17%
• image analysis 16%
• Respiratory syncytial virus 14%
• granulocyte colony-stimulating factor 14%
• immunotherapy 13%
• natural killer cells 12%
• Orthomyxoviridae 11%
• luciferase 11%
• morbidity 10%
• animal models 8%
• vaccines 8%
• lungs 7%
• therapeutics 7%
• monitoring 6%